Zydus launches Aerolife Mini, to simplify inhaler use for asthma and COPD patients
Zydus Lifesciences, an innovation-led life-sciences company with an international presence, has launched Aerolife Mini, a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus
Zydus and Torrent Pharma sign licensing agreement to co-market innovative Semaglutide injection in…
Zydus Lifesciences, an innovation-led global life-sciences company and Torrent Pharma, a specialty-focused global pharmaceutical…
Lupin and Zydus sign licensing agreement for co-marketing innovative Semaglutide injection in India
Global pharma major Lupin has entered into a Licensing and Supply Agreement with Zydus Lifesciences, an innovation-led…
Zydus receives final approval from USFDA for Cevimeline Hydrochloride Capsules 30mg
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Cevimeline…
Zydus, RK Pharma enters into an exclusive licensing and commercialisation agreement for a novel…
Zydus Lifesciences, a global innovation-driven healthcare company, today announced that it has entered into an exclusive licensing…
Zydus receives final approval from US FDA for Verapamil Hydrochloride
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (US FDA) for Verapamil…
USFDA grants Orphan Drug Designation (ODD) to Zydus’ Desidustat for treatment of beta-thalassemia
Zydus, a leading, discovery-based, global pharmaceutical company announced that the USFDA has granted Orphan Drug Designation…
Zydus launches VaxiFlu, India’s first trivalent influenza vaccine
Zydus Lifesciences Ltd, a global innovation led healthcare company, launched its trivalent influenza (Flu) vaccine VaxiFlu…
Zydus Lifesciences to Acquire 85.6% of Amplitude Surgical, block acquisition expected by Q3 2025
Zydus signs share purchase agreement to acquire majority stake in Amplitude Surgical, subject to regulatory approval and closing…
Zydus receives final USFDA approval for Eluxadoline Tablets, 75 mg and 100 mg
Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea…